“biocryst-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test 12/10/19 Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
BioCryst Drops Idera Pharma Merger After Shareholders Veto Deal 07/10/18 Raleigh Durham
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
BioCryst Stock Tanks After Rare Disease Drug’s Phase 2 Failure 02/08/16 Raleigh Durham
BioCryst Licenses Flu Drug to CSL, Gains Cash For Rare Disease Work 06/17/15 Raleigh Durham
Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More 04/06/15 Raleigh Durham
BioCryst Ebola Drug Awarded Funding for Tests 08/29/14 Raleigh Durham
West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More 08/21/14 San Diego
North Carolina Roundup: BioCryst, Biotech Center, Validic, & More 08/19/14 Raleigh Durham
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
Xconomy Launches in Raleigh-Durham—10th Cluster in Our Network 07/24/14 National
Pico Pharmaceuticals, In Its Early Days, Aims to Make More Potent Cancer Drugs, Anti-Bacterials 03/16/09 San Diego
Page 1 of 1